ArticleCancer medicine2022

Safety and efficacy of atezolizumab plus bevacizumab in elderly patients with hepatocellular carcinoma: A multicenter analysis.

Toshifumi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.